You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 25, 2024

Litigation Details for TAKEDA PHARMACEUTICAL COMPANY LTD. v. INDOCO REMEDIES LTD. (D.N.J. 2017)

✉ Email this page to a colleague

« Back to Dashboard

TAKEDA PHARMACEUTICAL COMPANY LTD. v. INDOCO REMEDIES LTD. (D.N.J. 2017)

Docket	⤷ Sign Up	Date Filed	2017-09-20
Court	District Court, D. New Jersey	Date Terminated	2019-11-05
Cause	15:1126 Patent Infringement	Assigned To	Stanley R. Chesler
Jury Demand	None	Referred To	Cathy L. Waldor
Patents	7,807,689; 8,173,663; 8,288,539; 8,900,638
Link to Docket	External link to docket

Small Molecule Drugs cited in TAKEDA PHARMACEUTICAL COMPANY LTD. v. INDOCO REMEDIES LTD.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up , ⤷ Sign Up , and ⤷ Sign Up .

Details for TAKEDA PHARMACEUTICAL COMPANY LTD. v. INDOCO REMEDIES LTD. (D.N.J. 2017)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2019-05-08	57		CLAIMS AND COUNTERCLAIMS PERTAINING TO U.S. PATENT NO. 8,900,638; Pursuant to Rule 41 (a)(l)(A)(ii) of the… 5 November 2019 2:17-cv-07301-SRC-CLW Patent - Abbreviated New Drug Application(ANDA) None	External link to document
2019-10-02	74		of record and assignee of U.S. Patent No. 7,807,689 (‘the °689 patent’) and has been at all times relevant…establish the invalidity of U.S. Patent No. 7,807,689 (the “689 patent”) at trial and/or in rebuttal to…determining the patentability of the 689 patent. 13. The Patent Office found the °689 patent claims patentable…obviousness-type double patenting over claim 162 of U.S. Patent No. 7,723,444 (the “Feng patent”) in view of Kim…is not patentably distinct from asserted claims 4 and 12 of the °689 patent. 21. The Feng patent issued	External link to document
2020-02-04	82	Opinion	double patenting. 17. Claims 4 and 12 of U.S. Patent No. 7,807,689 are valid patent claims.…Torrent.”) Plaintiffs own U.S. Patent No. 7,807,689 (“the ’689 patent”), which is listed in the Orange…second patent for claims that are not patentably distinct from the claims of the first patent. It …claims in a second patent not patentably distinct from the claims of the first patent. The obviousness-type… claims 4 and 12 of the ’689 patent. A bench trial on Defendants’ patent invalidity defenses to infringement	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.